Hepion Pharmaceuticals, Inc.
HEPA- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001583771
In the last 90 days, Hepion Pharmaceuticals, Inc. insiders filed 5 open-market purchases and 0 sales; 1 institution reported holding it in 13F filings for Q2 2026, worth $0 in total; no superinvestor holds it.
Other share classesCTRVP
13F holders, Q1 2022
Institutional positions in Hepion Pharmaceuticals, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 38
- −4 vs. Q4 2021
- Shares held
- 7.56M
- −243.5K (−3.1%) vs. Q4 2021
- Total value
- $9.74M
- +$853.5K (+9.6%) vs. Q4 2021
- New holders
- 5
- 9 more added
- Sold out
- 9
- 11 more reduced
1 institution that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting HEPA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $0 |
| Q1 2026 | 1 | $0 |
| Q4 2025 | 1 | $0 |
| Q3 2025 | 1 | $0 |
| Q2 2025 | 4 | $1.39K |
| Q1 2025 | 16 | $419.7K |
| Q4 2024 | 22 | $215.4K |
| Q3 2024 | 22 | $338.2K |
| Q2 2024 | 24 | $863.9K |
| Q1 2024 | 25 | $1.77M |
| Q4 2023 | 24 | $2.42M |
| Q3 2023 | 24 | $4.00M |
| Q2 2023 | 23 | $5.43M |
| Q1 2023 | 32 | $5.60M |
| Q4 2022 | 32 | $2.20M |
| Q3 2022 | 32 | $3.61M |
| Q2 2022 | 34 | $4.24M |
| Q1 2022 | 38 | $9.74M |
| Q4 2021 | 43 | $9.00M |
| Q3 2021 | 42 | $11.9M |
| Q2 2021 | 49 | $21.3M |
| Q1 2021 | 45 | $14.7M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Hepion Pharmaceuticals, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bank of America Corp | 5 | $0 | 0.00% | −31,144−100.0% | Reduced |
| Signaturefd, LLC | 2 | $0 | 0.00% | 00.0% | Unchanged |
| Harbor Investment Advisory, LLC | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Capital Advisors, Ltd. LLC | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 309 | $0 | 0.00% | +309 | New |
| Wells Fargo & Company | 469 | $1.00K | 0.00% | +1+0.2% | Added |
| UBS Group AG | 1,845 | $2.00K | 0.00% | −8,264−81.7% | Reduced |
| Tower Research Capital LLC (TRC) | 1,880 | $2.00K | 0.00% | +1,880 | New |
| Federation des caisses Desjardins du Quebec | 3,500 | $4.51K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 4,000 | $5.00K | 0.00% | +4,000 | New |
| Benjamin F. Edwards & Company, Inc. | 4,501 | $6.00K | 0.00% | 00.0% | Unchanged |
| Geneos Wealth Management Inc. | 5,000 | $6.00K | 0.00% | 00.0% | Unchanged |
| Prospera Financial Services Inc | 8,000 | $10.0K | 0.00% | +8,000 | New |
| Commonwealth Equity Services, LLC | 10,001 | $12.0K | 0.00% | +10.0% | Added |
| Amplius Wealth Advisors, LLC | 10,000 | $12.0K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 12,453 | $16.0K | 0.00% | −23,668−65.5% | Reduced |
| JGP Wealth Management, LLC | 15,000 | $17.0K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 14,956 | $19.0K | 0.00% | −20,183−57.4% | Reduced |
| Advisor Group Holdings, Inc. | 22,989 | $29.0K | 0.00% | −400−1.7% | Reduced |
| Jane Street Group, LLC | 23,421 | $30.0K | 0.00% | −23,478−50.1% | Reduced |
| Charles Schwab Investment Management Inc | 31,535 | $41.0K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 37,563 | $48.0K | 0.00% | +422+1.1% | Added |
| Group One Trading, L.P. | 47,903 | $62.0K | 0.00% | +7,448+18.4% | Added |
| Susquehanna International Group, LLP | 49,499 | $64.0K | 0.00% | −39,158−44.2% | Reduced |
| Boothbay Fund Management, LLC | 55,599 | $72.0K | 0.00% | 00.0% | Unchanged |
| The PNC Financial Services Group, Inc. | 57,534 | $74.0K | 0.00% | 00.0% | Unchanged |
| Envestnet Asset Management Inc | 57,778 | $75.0K | 0.00% | −14,249−19.8% | Reduced |
| McAdam, LLC | 62,169 | $80.0K | 0.01% | +10.0% | Added |
| Two Sigma Advisers, LP | 81,900 | $106.0K | 0.00% | −24,600−23.1% | Reduced |
| Renaissance Technologies LLC | 126,600 | $163.0K | 0.00% | +76,300+151.7% | Added |
| Northern Trust Corp | 142,204 | $184.0K | 0.00% | +1,205+0.9% | Added |
| Bank of New York Mellon Corp | 158,394 | $204.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 348,910 | $450.0K | 0.00% | +26,194+8.1% | Added |
| Ikarian Capital, LLC | 582,137 | $751.0K | 0.23% | +28,864+5.2% | Added |
| Geode Capital Management, LLC | 658,110 | $848.0K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 1,612,627 | $2.08M | 0.00% | −11,278−0.7% | Reduced |
| Vanguard Group Inc | 3,308,523 | $4.27M | 0.00% | −17,494−0.5% | Reduced |
| IFP Advisors, Inc | 1 | – | – | +1 | New |
| Virtu Financial LLC | 0 | $0 | 0.00% | −49,959−100.0% | Sold out |
| Aristides Capital LLC | 0 | $0 | 0.00% | −49,496−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −24,200−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −20,556−100.0% | Sold out |
| Sabby Management, LLC | 0 | $0 | 0.00% | −20,479−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −15,900−100.0% | Sold out |
| Migdal Insurance & Financial Holdings Ltd. | 0 | $0 | 0.00% | −1,627−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| PVG Asset Management Corp | – | – | – | – | Not filed |